newsfilter
← Latest News
GlobeNewswire·

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® ("ReShape" or the "Company") (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the